A study of the prevalence and risk factors of foot problems in a population of diabetic patients in Cameroon

International Journal of Lower Extremity Wounds

Volumn 5, Issue 2, 2006, Pages 83-88

  Agbor, E A ^a,c   Tchakonte, Baudouin ^b   Mbanya, Jean Claude ^a  

^a YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^b Institut Pasteur de Cayenne   (French Guiana)

^c NONE   (Cameroon)

Author keywords

Diabetic foot; Prevalence; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAMEROON; CLINICAL TRIAL; DIABETIC FOOT; DIABETIC NEUROPATHY; FEMALE; FOOT CARE; HUMAN; LIMB ISCHEMIA; LIMB MALFORMATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAIL; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

EID: 33646595016     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734606288413     Document Type: Article

References (28)

1. Diabetes mellitus: report of the Expert Committee on Diabetes. Geneva, Switzerland: World Health Organisation; 1985.
2. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P. Showstack JA. Lower extremity amputations in people with diabetes: epidemiology and prevention. Diabetes Care 1989;12:24-31.
3. Songer TJ. The role of cost effectiveness analysis and health insurance in diabetes care. Diabetes Res Clin Pract 2001;54(Suppl 1):S7-11.
4. Litzelman DK, Marriot DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 1997;20(8):1273-8.
5. Davidson JK, Alogna M, Goldsmith M, Borden J. Assessment of program effectiveness at Grady Memorial Hospital-Atlanta. In: Steiner G, Lawrence PA, editors. Educating diabetic patients. New York: Springer Verlag; 1991. p. 329-48.
6. Holstein P, Ellitsgaard N, Sorensen S, Bornefeldt Olsen B, Black E, et al. The number of amputations has decreased. Nord Med 1996;111:142-44.
7. Ramsey SC, Newton K, Blough D, Mc Cullock DK, Sandhu N. Incidence, outcomes and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-7.
8. Ama Moor VJN. M.D. Thèse: Faculté de Médecine et de Sciences Biomédicales, Université de Yaounde I: Estimation du coût direct et indirect de la prise en charge du diabète en l'absence de complications chroniques en consultation externe d'Endocrinologie a l'Hôpital Central de Yaoundé. Année académique 2001-2002.
9. Young MJ, Boulton AJM, Macleod AF, William DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-4.
10. Delbridge L, Ctercteko G, Fowler C, Reeve TS, Le Quesne LP. The aetiology of diabetic neuropathic ulceration of the foot. Br J Surg 1985;72:1-6.
11. Sims DS Jr, Cavanagh PR, Ulbrecht JS. Risk factors in the diabetic foot: recognition and management. Phys Ther 1988;68:1887-902.
12. Holewski JJ, Moss KM, Stess RM, Graf PM, Grunfeld C. Prevalence of foot pathology and lower extremity complications in a diabetic out patient clinic. J Rehabil Res Dev 1989;26:35-44.
13. Mbanya JC, Dzudie AL, Kengne AP, Fezeu LL, Ndong W. Impact of secondary foot complications on the in-patient department of the Diabetes Unit of Yaounde central Hospital. Cameroon J Med 2001;10(1):38-9.
14. Thompson FJ, Veves A, Ashe H, Knowles EA, Gem J, Walker MG, et al. A team approach to diabetic foot care: the Manchester experience. Foot 1991:2:75-82.
15. Frykberg RG. Team approach toward lower extremity amputation prevention in diabetes. J Am Podiatr Med Assoc 1997;87:305-12.
16. Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981;2:64-122.
17. Reiber RE, Villeikyte L, Boyko EJ, Del Aguilla M, Smith DG. Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22:157-62.
18. Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower extremity complications: use of Semmes Weinstein monofilaments. Phys Ther 1996;76:68-71.
19. Rith-Najarian SJ. Identifying diabetic patients at high risk for lower extremity amputation in a primary health care setting. Diabetes Care 1992;15:1386-9.
20. Prescrire Redaction. Diabète: prévenir les lésions graves des pieds. Rev Prescr 2000;21(215).
21. Bril V, Perkins BA. Validation of the Toronto Clinical Scoring for Diabetic Polyneuropathy. Diabetes Care 2002;25:2048-52.
22. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes. Ann Intern Med 1992;117:97-105.
23. Partanen J, Niskanen, Lehtinen J, Marvaala E, Siitonene O. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus. N Engl J Med 1995;333:89-94.
24. Franklin GF, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuropathy in NIDDM: the San Luis Valley Diabetes Study. Diabetes Care 1994;17:1172-7.
25. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system: the contribution of depth, infection and ischaemia to the risk of amputation. Diabetes Care 1998;21(5):855-62.
26. Sano D, Tieno H, Drabo Y, Sanou A. Prise en charge du pied diabétique: a propos de 42 cas au C.H.U. de ouagadougou. Médicine d'Afrique Noire 1996;46(6):308-11.
27. Lester FT. Amputations in patients attending a diabetic clinic in Addis Abebe, Ethiopia. Ethiop Med J 1995;33:15-19.
28. Lokrou X, Yassi NL, Turquin H. L'artérite de membre inférieur chez le diabétique a Abidjan. Etude transversale sur 663 diabétiques. Revue Française d'endocrinologie clinique, Nutrition et Métabolisme 1994;35(6):553-5.